Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications in Patients Undergoing Invasive Procedures in the Hybrid Cardiac Catheterization/Cardiac Surgery Suite

NCT00603148 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00603148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00603148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications in Patients Undergoing Invasive Procedures in the Hybrid Cardiac Catheterization/Cardiac Surgery Suite
Lead sponsor
Vanderbilt University
Phase
Observational
Overall status
Completed
Start date
September 30, 2006
Completion date
February 28, 2010
Enrollment
475 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic polymorphism